Correlation Between Veracyte and Climb Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Veracyte and Climb Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Climb Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Climb Bio, you can compare the effects of market volatilities on Veracyte and Climb Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Climb Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Climb Bio.

Diversification Opportunities for Veracyte and Climb Bio

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Veracyte and Climb is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Climb Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Climb Bio and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Climb Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Climb Bio has no effect on the direction of Veracyte i.e., Veracyte and Climb Bio go up and down completely randomly.

Pair Corralation between Veracyte and Climb Bio

Given the investment horizon of 90 days Veracyte is expected to generate 1.39 times less return on investment than Climb Bio. But when comparing it to its historical volatility, Veracyte is 2.2 times less risky than Climb Bio. It trades about 0.06 of its potential returns per unit of risk. Climb Bio is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  261.00  in Climb Bio on August 27, 2024 and sell it today you would earn a total of  44.00  from holding Climb Bio or generate 16.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Veracyte  vs.  Climb Bio

 Performance 
       Timeline  
Veracyte 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Veracyte are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Veracyte unveiled solid returns over the last few months and may actually be approaching a breakup point.
Climb Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Climb Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Veracyte and Climb Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Veracyte and Climb Bio

The main advantage of trading using opposite Veracyte and Climb Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Climb Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Climb Bio will offset losses from the drop in Climb Bio's long position.
The idea behind Veracyte and Climb Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing